EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 2 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $40,654 | -53.7% | 11,957 | 0.0% | 0.01% | -50.0% |
Q2 2023 | $87,884 | -29.1% | 11,957 | 0.0% | 0.01% | -28.6% |
Q1 2023 | $123,875 | -12.3% | 11,957 | 0.0% | 0.01% | -22.2% |
Q4 2022 | $141,212 | -43.7% | 11,957 | 0.0% | 0.02% | -60.9% |
Q3 2022 | $251,000 | -9.7% | 11,957 | +33.7% | 0.05% | -36.1% |
Q2 2022 | $278,000 | -24.3% | 8,945 | 0.0% | 0.07% | -18.2% |
Q1 2022 | $367,000 | – | 8,945 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 20,591 | $895,000 | 1.43% |
Global Alpha Capital Management Ltd. | 330,270 | $14,357,000 | 1.39% |
AIMZ Investment Advisors, LLC | 73,875 | $3,211,000 | 1.25% |
Hillcrest Asset Management LLC | 184,010 | $7,999,000 | 1.22% |
Bridge City Capital, LLC | 56,869 | $2,472,000 | 1.02% |
SNYDER CAPITAL MANAGEMENT L P | 683,700 | $29,720,000 | 0.72% |
EARNEST PARTNERS LLC | 2,188,606 | $95,139,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 343,347 | $14,925,000 | 0.53% |
PALISADE CAPITAL MANAGEMENT, LP | 584,957 | $25,428,000 | 0.52% |
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 45,693 | $1,986,000 | 0.45% |